Table: Daito -Q1 group results

Daito Pharmaceutical

11/10/2018 07:00

Oct 11 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2018        Aug 31, 2017     May 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.74                9.68             40.80    
                 (+0.6 pct)          (+6.3 pct)       (+2.3 pct)  
  Operating         1.09               932 mln            4.30    
                 (+17.4 pct)         (+0.2 pct)       (+3.3 pct)  
  Recurring         1.14               973 mln            4.35    
                 (+17.2 pct)         (+0.6 pct)       (+2.5 pct)  
  Net              779 mln             673 mln            3.10    
                 (+15.8 pct)         (+0.2 pct)       (+1.9 pct)  
  EPS             62.32 yen           53.80 yen       247.72 yen  
  Ann Div                             33.00 yen        36.00 yen  
  -Q2 div                             15.00 yen        18.00 yen  
  -Q4 div                             18.00 yen        18.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T